Search Results - "Arrisi, Pablo"

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion by Hattenbach, Lars-Olof, Abreu, Francis, Arrisi, Pablo, Basu, Karen, Danzig, Carl J., Guymer, Robyn, Haskova, Zdenka, Heier, Jeffrey S., Kotecha, Aachal, Liu, Ying, Loewenstein, Anat, Seres, András, Willis, Jeffrey R., Wykoff, Charles C., Paris, Liliana P.

“…Dual inhibition of angiopoietin-2 and VEGF-A with faricimab (Vabysmo) offers excellent visual acuity gains with strong durability in patients with diabetic…”
Get full text

P069 Correlation Between Histologic Indices and Ulcerative Colitis Activity Measures Among Patients in the HICKORY (Etrolizumab) Open-Label Induction Cohort by Peyrin-Biroulet, Laurent, Feagan, Brian, Pai, Rish, Boruvka, Audrey, Oh, Young, Scherl, Alexis, Scalori, Astrid, Arrisi, Pablo, Tole, Swati, Rubin, David

“…BACKGROUND: Cross-sectional studies in ulcerative colitis (UC) have shown at best a moderate association between histologic and clinical measures of disease…”
Get full text

Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene by Mercado, Pablo Arrisi, Ayala, Youhna M., Romano, Maurizio, Buratti, Emanuele, Baralle, Francisco E.

“…Exon 3 of the human apolipoprotein A-II (apoA-II) gene is efficiently included in the mRNA although its acceptor site is significantly weak because of a…”
Get full text

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale by Hattenbach, Lars-Olof, Abreu, Francis, Arrisi, Pablo, Basu, Karen, Danzig, Carl J, Guymer, Robyn, Haskova, Zdenka, Heier, Jeffrey S, Kotecha, Aachal, Liu, Ying, Loewenstein, Anat, Seres, András, Willis, Jeffrey R, Wykoff, Charles C, Paris, Liliana P

“…PurposeDual inhibition of angiopoietin-2 and VEGF-A with faricimab (Vabysmo) offers excellent visual acuity gains with strong durability in patients with…”
Get full text

Chapter 7. Nonsense-mediated mRNA decay in Caenorhabditis elegans by Longman, Dasa, Arrisi, Pablo, Johnstone, Iain L, Cáceres, Javier F

“…The nonsense-mediated mRNA decay (NMD) pathway is a surveillance mechanism that targets the degradation of mRNAs harboring premature termination codons (PTCs)…”
Get more information

An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3′ Splice Site of Human Apolipoprotein A-II Exon 3 by Pablo Arrisi-Mercado, Maurizio Romano, Andres F. Muro, Francisco E. Baralle

“…Human apolipoprotein A-II (apoA-II) intron 2/exon 3 junction shows a peculiar tract of alternating pyrimidines and purines (GU tract) that makes the acceptor…”
Get full text

An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3′ Splice Site of Human Apolipoprotein A-II Exon 3 by Arrisi-Mercado, Pablo, Romano, Maurizio, Muro, Andres F., Baralle, Francisco E.

“…Human apolipoprotein A-II (apoA-II) intron 2/exon 3 junction shows a peculiar tract of alternating pyrimidines and purines (GU tract) that makes the acceptor…”
Get full text

Molecular Basis of The Human ApoAII Exon 3 Splicing by Arrisi Mercado, Pablo

“…Among human genes, CFTR intron VIII/exon 9 and apolipoprotein All intron II/exon 3 boundaries share the characteristic feature given by the presence of a…”
Get full text